Get the Stockscreener App
1.49
3.47%
0.05
Lava Therapeutics Nv stock is traded at $1.49, with a volume of 8,779.
It is up +3.47% in the last 24 hours and up +12.45% over the past month.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.44
Open:
$1.45
24h Volume:
8,779
Relative Volume:
0.27
Market Cap:
$39.19M
Revenue:
$9.06M
Net Income/Loss:
$-50.39M
P/E Ratio:
-0.776
EPS:
-1.92
Net Cash Flow:
$5.89M
1W Performance:
+5.67%
1M Performance:
+12.45%
6M Performance:
+54.72%
1Y Performance:
-26.96%
1-Day Range:
$1.44
$1.50
1-Week Range:
$1.39
$1.57
52-Week Range:
$0.8502
$2.21
Lava Therapeutics Nv Stock (LVTX) Company Profile
Name
Lava Therapeutics Nv
Sector
Industry
Phone
31 6 3000 3035
Address
YALELAAN 62, UTRECHT
Compare LVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.49 | 36.83M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.55 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.08 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.43 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.02 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Oct-25-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-21 | Initiated | JP Morgan | Overweight |
| Apr-19-21 | Initiated | Jefferies | Buy |
| Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Lava Therapeutics Nv Stock (LVTX) Latest News
What analysts say about LAVA Therapeutics N.V. stockRapid return acceleration - Autocar Professional
LAVA Therapeutics N.V. Stock Analysis and ForecastRemarkable growth - Autocar Professional
The Best Indian Stocks for Portfolio Diversification Professional Stock Selection ToolsFree Wealth Management Insights - Autocar Professional
Best Gold Stocks to Buy AI Stock InsightsExceptional stock performance - Autocar Professional
AgEagle Aerial Systems Inc. Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com
What drives LAVA Therapeutics N.V. stock priceFree Stock Market Trend Analysis - Autocar Professional
Is LAVA Therapeutics N.V. a good long term investmentFree Consultation - jammulinksnews.com
Personalis Inc. Stock Analysis and ForecastMassive stock growth - jammulinksnews.com
Sigachi Industries Limited (SIGACHI) Announces Strategic ShiftFree Trading Psychology Coaching - Autocar Professional
Is Universal Corporation a good long term investmentSuperior trading gains - Autocar Professional
Best Mid Cap Growth Stocks Elite Trader Market TipsPhenomenal trading returns - PrintWeekIndia
TruCap Finance Limited (TRU) Hits 52 Week HighPowerful profit generation - Autocar Professional
Waaree Energies Limited (544277) Quarterly Results Are OutFree Predictions - jammulinksnews.com
What analysts say about ACCO stockRobust investment performance - jammulinksnews.com
What drives Nucor Corporation stock priceFree Market Volatility Navigation Tips - jammulinksnews.com
P500 stockConsistent triple returns - jammulinksnews.com
What analysts say about SARO stockExceptional earning trajectories - jammulinksnews.com
What drives ARGD stock priceExplosive wealth accumulation - jammulinksnews.com
How LAVA Therapeutics N.V. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
Why LAVA Therapeutics N.V. stock attracts strong analyst attentionHigh Return Setup Scanner - Newser
What makes Hurco Companies Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser
What makes LAVA Therapeutics N.V. stock price move sharplyMassive Gain Ideas - Newser
How C PROCL stock performs during market volatilityFree Stock Market Forums - Newser
Earning from Blockchain Based Digital Wallet ServicesFree Deep Market Trend Analysis - Newser
LAVA Therapeutics Shareholders Approve Key Proposals in Meeting - TipRanks
LAVA Therapeutics NV reports results for the quarter ended March 31Earnings Summary - TradingView
Here's Why We're Watching LAVA Therapeutics' (NASDAQ:LVTX) Cash Burn Situation - Yahoo Finance
LAVA Therapeutics (LVTX) Receives Reiterated Market Perform Rati - GuruFocus
LAVA Reports First Quarter 2025 Financial Results, Provides Business Update - GlobeNewswire
LAVA (LVTX) Pursues Strategic Moves Amid Workforce Restructuring - GuruFocus
LAVA Therapeutics Slashes 30% Workforce, Closes Netherlands Operations Amid Strategic Review - Stock Titan
RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com
LAVA Therapeutics Strengthens Balance Sheet with $5.1 Million Repayment Waiver from Netherlands Enterprise Agency - Nasdaq
Lava Therapeutics Granted Full Waiver For RVO Payment Obligation - marketscreener.com
LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation - GlobeNewswire
LAVA Therapeutics Strengthens Balance Sheet: Secures Complete Waiver of $5.1M Debt - Stock Titan
Lava Therapeutics Nv Stock (LVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.72%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):